Necrotizing otitis externa – Benefit of a multimodal treatment concept
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S294
DOI: 10.1055/s-0044-1784986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Maximilian Hupfer und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Necrotizing otitis externa is a serious complication of inflammation of the external auditory canal and ultimately leads to osteomyelitis of the skull base due to the spread of infection via the Santorini fissures [Nadol 1980]. It is associated with diabetes mellitus and Pseudomonas aeruginosa [O'Sullivan et al. 1978]. If the facial nerve is involved, the mortality rate is up to 15% [Glikson et al. 2016]. The following case series is intended to demonstrate the need for multimodal therapy. Material and methods Presentation of a retrospective case series n=18 at the Nuremberg ENT Clinic (Paracelsus Medical University). Data was collected from 2019 to 2023. The current disease status was defined in a telephone conference in November 2023. The criteria for follow-up were the first post-inpatient follow-up imaging and the development of facial nerve palsy.
Results
18 patients (age of 84±6 years) with the diagnostic criteria otalgia/otorrhea with the presence of bony arrosions of the temporal bone were included. 94% (17/18) of the patients had diabetes type II, 89% (16/18) had Pseudomonas aeruginosa and 44% (8/18) also had fungi in the microbiological swab. The mean duration of hospitalization was 52.6±26 days. During this time, consistent multimodal therapy was carried out. The mean duration of systemic antibiotic therapy was 83.2±30 days. In patients with facial nerve palsy n=5, an improvement in the House-Brackmann Index of 0.75±0.8 points was achieved.
Discussion
The results show the necessity of a consistent and usually lengthy multimodal therapy concept. This is the only way to positively influence the course of the disease, particularly with regard to associated facial nerve palsy and disease-specific mortality. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Hupfer, M., Faderl, J., Knebel, I., Ulbrich, V., Sommer, L., Schapher, M., & Traxdorf, M. (2024). Necrotizing otitis externa – Benefit of a multimodal treatment concept. Laryngo-Rhino-Otologie, 103(S 02 S 02), S294. https://doi.org/10.1055/s-0044-1784986
Vancouver
Hupfer M, Faderl J, Knebel I, Ulbrich V, Sommer L, Schapher M, et al. Necrotizing otitis externa – Benefit of a multimodal treatment concept. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S294. doi:10.1055/s-0044-1784986
BibTeX
@article{Hupfer2024,
author = {Hupfer, Maximilian and Faderl, Jana and Knebel, Igor and Ulbrich, Vanessa and Sommer, Laura and Schapher, Mirco and Traxdorf, Maximilian},
title = {Necrotizing otitis externa – Benefit of a multimodal treatment concept},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S294},
doi = {10.1055/s-0044-1784986}
}
EUVIMED